- $3.04bn
- $2.60bn
- $709.00m
Annual income statement for Netskope, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | USG | USG | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 407 | 538 | 709 |
| Cost of Revenue | |||
| Gross Profit | 243 | 348 | 483 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Total Operating Expenses | 720 | 794 | 1,362 |
| Operating Profit | -313 | -256 | -653 |
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -338 | -350 | -668 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -345 | -355 | -679 |
| Net Income Before Extraordinary Items | |||
| Net Income | -345 | -355 | -679 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -345 | -355 | -679 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.903 | -0.928 | -3.18 |